Sippel C J, Suchy F J, Ananthanarayanan M, Perlmutter D H
Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110.
J Biol Chem. 1993 Jan 25;268(3):2083-91.
A approximately 110-kDa glycoprotein purified from canalicular vesicles by bile acid affinity chromatography has been identified as the canalicular bile acid transport protein. Internal amino acid sequence and chemical and immunochemical characteristics of this protein were found to be identical to a rat liver canalicular ecto-ATPase. In order to definitively determine whether these were two activities of a single polypeptide, we examined the possibility that transfection of cDNA for the ecto-ATPase would confer bile acid transport characteristics, as well as ecto-ATPase activity, on heterologous cells. The results show that transfection of the ecto-ATPase cDNA conferred on COS cells de novo synthesis of a approximately 110-kDa polypeptide, as immunoprecipitated by antibody to the purified canalicular bile acid transport protein and conferred on COS cells the capacity to pump out [3H]taurocholate with efflux characteristics comparable with those previously determined in canalicular membrane vesicles (Km = 100 microM; Vmax = 200 pmol/mg of protein/20 s). A truncated ecto-ATPase cDNA, missing the cytoplasmic tail, was targeted correctly to the cell surface but did not confer bile acid transport activity on COS cells. The results of this study also show that the canalicular ecto-ATPase/bile acid transport protein is phosphorylated on its cytoplasmic tail and that its phosphorylation is stimulated by activation of protein kinase C and inhibited by inhibitors of protein kinase C activation. Moreover, inhibition of protein kinase C activation by staurosporine completely abrogates bile acid transport but does not affect ATPase activity. This study, therefore, demonstrates that the rat liver canalicular ecto-ATPase is also a bile acid transport protein, that the capacity to pump out bile acid can be conferred on a heterologous cell by DNA-mediated gene transfer, and that phosphorylation within the cytoplasmic tail of the transporter is essential for bile acid efflux activity but not for ATPase activity.
通过胆汁酸亲和层析从胆小管囊泡中纯化得到的一种约110 kDa的糖蛋白已被鉴定为胆小管胆汁酸转运蛋白。该蛋白的内部氨基酸序列以及化学和免疫化学特性被发现与大鼠肝脏胆小管外向ATP酶相同。为了明确确定这是否是单一多肽的两种活性,我们研究了转染外向ATP酶的cDNA是否会赋予异源细胞胆汁酸转运特性以及外向ATP酶活性的可能性。结果表明,外向ATP酶cDNA的转染使COS细胞从头合成了一种约110 kDa的多肽,该多肽可被针对纯化的胆小管胆汁酸转运蛋白的抗体免疫沉淀,并赋予COS细胞泵出[3H]牛磺胆酸盐的能力,其流出特性与先前在胆小管膜囊泡中测定的相当(Km = 100 microM;Vmax = 200 pmol/mg蛋白质/20秒)。一个缺失细胞质尾巴的截短外向ATP酶cDNA被正确靶向到细胞表面,但未赋予COS细胞胆汁酸转运活性。这项研究的结果还表明,胆小管外向ATP酶/胆汁酸转运蛋白在其细胞质尾巴上被磷酸化,其磷酸化受到蛋白激酶C激活的刺激,并受到蛋白激酶C激活抑制剂的抑制。此外,星形孢菌素对蛋白激酶C激活的抑制完全消除了胆汁酸转运,但不影响ATP酶活性。因此,这项研究表明,大鼠肝脏胆小管外向ATP酶也是一种胆汁酸转运蛋白,通过DNA介导的基因转移可以赋予异源细胞泵出胆汁酸的能力,并且转运蛋白细胞质尾巴内的磷酸化对于胆汁酸流出活性至关重要,但对于ATP酶活性并非如此。